Nao metam tudo no mesmo saco..... meter a Kbios no saco de uma cotada com mais liquidez parece um erro ...
Alem disso vejam isto......o outro shortou porque lhe apeteceu ou foi atras de uma dica de alguem
:
Press Releases
Year:
All Releases
View Summary KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New FinancingNov 19, 2015 PDF 27.1 KB Add to Briefcase
View Summary KaloBios Confirms Communications with Majority Shareholder GroupNov 18, 2015 PDF 27.5 KB Add to Briefcase
View Summary KaloBios to Wind Down OperationsNov 13, 2015 PDF 26.4 KB Add to Briefcase
View Summary KaloBios to Reduce Workforce, Explore Strategic AlternativesNov 5, 2015 PDF 28.3 KB Add to Briefcase
View Summary KaloBios to Present at 14th Annual BIO Investor Forum
Oct 15, 2015 PDF 28.2 KB Add to Briefcase
View Summary KaloBios Reports Second Quarter Financial Results and Provides Clinical Update
Aug 10, 2015 PDF 36.7 KB Add to Briefcase
View Summary KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic LeukemiaJul 29, 2015 PDF 36.9 KB Add to Briefcase
View Summary KaloBios Regains Compliance with NASDAQ Minimum Bid Price RequirementJul 29, 2015 PDF 35.4 KB Add to Briefcase
View Summary KaloBios Announces Shareholders and Board of Directors Approval of Reverse Stock SplitJul 13, 2015 PDF 28.8 KB Add to Briefcase
View Summary KaloBios to Present at the JMP Securities Life Sciences Conference
Jun 17, 2015 PDF 28.5 KB Add to Briefcase
View Summary KaloBios Appoints Ronald A. Martell Executive Chairman
May 28, 2015 PDF 28.9 KB Add to Briefcase
View Summary KaloBios Reports First Quarter 2015 Financial Results
May 11, 2015 PDF 34.1 KB Add to Briefcase
View Summary KaloBios Elects Ronald A. Martell to Board of Directors
Apr 22, 2015 PDF 28.5 KB Add to Briefcase
View Summary KaloBios to Present at the 14th Annual Needham Healthcare Conference
Apr 6, 2015 PDF 29.0 KB Add to Briefcase
View Summary KaloBios Reports Fourth Quarter 2014 Financial Results
Mar 16, 2015 PDF 42.6 KB Add to Briefcase
View Summary KaloBios Announces Upcoming Investor Conference Participation
Feb 3, 2015 PDF 30.5 KB Add to Briefcase
View Summary KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive OfficerJan 8, 2015 PDF 29.9 KB Add to Briefcase
View Summary KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients
Jan 6, 2015 PDF 32.8 KB Add to Briefcase
View Summary KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors
Dec 1, 2014 PDF 29.2 KB Add to Briefcase
View Summary KaloBios Announces Upcoming Scientific and Investor Conference Participation
Nov 11, 2014